Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21,178 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study.
Oaknin A, Pothuri B, Gilbert L, Sabatier R, Brown J, Ghamande S, Mathews C, O'Malley DM, Kristeleit R, Boni V, Gravina A, Banerjee S, Miller R, Pikiel J, Mirza MR, Dewal N, Antony G, Dong Y, Zografos E, Veneris J, Tinker AV. Oaknin A, et al. Among authors: brown j. Clin Cancer Res. 2023 Nov 14;29(22):4564-4574. doi: 10.1158/1078-0432.CCR-22-3915. Clin Cancer Res. 2023. PMID: 37363992 Free PMC article.
A plain language summary of results from the GARNET study of dostarlimab in patients with endometrial cancer.
Oaknin A, Gilbert L, Tinker AV, Brown J, Mathews C, Press J, Sabatier R, O'Malley DM, Samouelian V, Boni V, Duska L, Ghamande S, Ghatage P, Kristeleit R, Leath C 3rd, Dong Y, Veneris J, Pothuri B. Oaknin A, et al. Among authors: brown j. Future Oncol. 2023 Aug;19(25):1709-1714. doi: 10.2217/fon-2022-1157. Epub 2023 Jun 29. Future Oncol. 2023. PMID: 37381977 Review.
Antitumor Activity and Safety of Dostarlimab Monotherapy in Patients With Mismatch Repair Deficient Solid Tumors: A Nonrandomized Controlled Trial.
André T, Berton D, Curigliano G, Sabatier R, Tinker AV, Oaknin A, Ellard S, de Braud F, Arkenau HT, Trigo J, Gravina A, Kristeleit R, Moreno V, Abdeddaim C, Vano YA, Samouëlian V, Miller R, Boni V, Torres AA, Gilbert L, Brown J, Dewal N, Dabrowski C, Antony G, Zografos E, Veneris J, Banerjee S. André T, et al. Among authors: brown j. JAMA Netw Open. 2023 Nov 1;6(11):e2341165. doi: 10.1001/jamanetworkopen.2023.41165. JAMA Netw Open. 2023. PMID: 37917058 Free PMC article. Clinical Trial.
Measurement of CP Violation Observables in D^{+}→K^{-}K^{+}π^{+} Decays.
Aaij R, Abdelmotteleb ASW, Abellan Beteta C, Abudinén F, Ackernley T, Adefisoye AA, Adeva B, Adinolfi M, Adlarson P, Agapopoulou C, Aidala CA, Ajaltouni Z, Akar S, Akiba K, Albicocco P, Albrecht J, Alessio F, Alexander M, Aliouche Z, Alvarez Cartelle P, Amalric R, Amato S, Amey JL, Amhis Y, An L, Anderlini L, Andersson M, Andreianov A, Andreola P, Andreotti M, Andreou D, Anelli A, Ao D, Archilli F, Argenton M, Arguedas Cuendis S, Artamonov A, Artuso M, Aslanides E, Ataíde Da Silva R, Atzeni M, Audurier B, Bacher D, Bachiller Perea I, Bachmann S, Bachmayer M, Back JJ, Baladron Rodriguez P, Balagura V, Baldini W, Balzani L, Bao H, Baptista de Souza Leite J, Barbero Pretel C, Barbetti M, Barbosa IR, Barlow RJ, Barnyakov M, Barsuk S, Barter W, Bartolini M, Bartz J, Basels JM, Bashir S, Bassi G, Batsukh B, Battista PB, Bay A, Beck A, Becker M, Bedeschi F, Bediaga IB, Behling NB, Belin S, Bellee V, Belous K, Belov I, Belyaev I, Benane G, Bencivenni G, Ben-Haim E, Berezhnoy A, Bernet R, Bernet Andres S, Bertolin A, Betancourt C, Betti F, Bex J, Bezshyiko I, Bhom J, Bieker MS, Biesuz NV, Billoir P, Biolchini A, Birch M, Bishop FCR, Bitadze A, Bizzeti A, Blake T, Blanc F, Blank JE, Blusk S… See abstract for full author list ➔ Aaij R, et al. Among authors: brown j. Phys Rev Lett. 2024 Dec 20;133(25):251801. doi: 10.1103/PhysRevLett.133.251801. Phys Rev Lett. 2024. PMID: 39752695
Basic Science and Pathogenesis.
Sander M, Lunnon K, Ballard CG, Brown JT. Sander M, et al. Among authors: brown jt. Alzheimers Dement. 2024 Dec;20 Suppl 1:e092346. doi: 10.1002/alz.092346. Alzheimers Dement. 2024. PMID: 39751239
Basic Science and Pathogenesis.
Flagan TM, Chu SA, Häkkinen S, Zhang L, McFall D, Heller C, Rohrer JD, Brown JA, Lee AJ, Fernhoff K, Pasquini L, Mandelli ML, Tempini MLG, Yokoyama JS, Sturm V, Appleby B, Dickerson BC, Domoto-Reilly K, Foroud TM, Geschwind DH, Ghoshal N, Graff-Radford NR, Grossman M, Hsiung GR, Huang EJ, Huey ED, Kantarci K, Karydas AM, Kaufer D, Knopman DS, Litvan I, MacKenzie IR, Mendez MF, Onyike CU, Petrucelli L, Ramos EM, Roberson ED, Rojas JC, Tartaglia MC, Toga AW, Weintraub S, Forsberg LK, Heuer HW, Boeve BF, Boxer AL, Rosen HJ, Miller BL, Moreno F, Seeley WW, Lee SE; ARTFL/LEFFTDS Consortia. Flagan TM, et al. Among authors: brown ja. Alzheimers Dement. 2024 Dec;20 Suppl 1:e087301. doi: 10.1002/alz.087301. Alzheimers Dement. 2024. PMID: 39751006
An updated overview on long-acting therapeutics for the prevention and treatment of human immunodeficiency virus (HIV) from a perspective of pharmaceutics.
Dinh L, Blackard JT, Robertson J, Atreya A, Horner S, Brown JL, Gomez LA, Beegle S, Mahon L, Eades W, Abdolmohammadpourbonab S, Liu W, Meeds HL, Fedders K, Twitty TD, Welge JA, Yan B. Dinh L, et al. Among authors: brown jl. Int J Pharm. 2024 Dec 31:125157. doi: 10.1016/j.ijpharm.2024.125157. Online ahead of print. Int J Pharm. 2024. PMID: 39746588 Review.
21,178 results
You have reached the last available page of results. Please see the User Guide for more information.